Skip to main content
# Title Department Research Year
151 Design, synthesis, apoptotic, and antiproliferative effects of 5-chloro-3-(2-methoxyvinyl)-indole-2-carboxamides and pyrido[3,4-b]indol-1-ones as potent EGFRWT/EGFRT790M inhibitors Department of Pharmaceutical Organic Chemistry 2023
152 Anatase titanium oxide nanoparticles and multi-walled carbon nanotubes-modified carbon paste electrode for simultaneous determination of avanafil and doxorubicin in plasma samples 2023
153 The design, synthesis, biological evaluation, and molecular docking of new 5-aminosalicylamide-4-thiazolinone hybrids as anticancer agents Department of Pharmaceutical Organic Chemistry 2023
154 Convenient electrochemical and fluorometric dual-mode estimation of diosmin using carbon dots doped with nitrogen derived from chicken feet biowaste 2023
155 Adenine model of chronic renal failure in rats to determine whether MCC950, an NLRP3 inflammasome inhibitor, is a renopreventive Department of Pharmacology 2023
156 Combined Experimental/Computational Aspects for the Molecular Interaction of Empagliflozin with Bovine Serum Albumin: Quantification, and Application to Human Plasma Department of Pharmaceutical Analytical Chemistry 2023
157 Synthesis, Antioxidant and Antiproliferative Actions of 4-(1,2,3-Triazol-1-yl) Quinolin-2(1H)-Ones as Multi-Target Inhibitors Department of Pharmaceutical Organic Chemistry 2023
158 Phytochemical analysis and anti-infective potential of fungal endophytes isolated from Nigella sativa seeds Department of Pharmaceutical Organic Chemistry 2023
159 Nanotechnology-Based Strategies to Combat Multidrug-Resistant Candida auris Infections 2023
160 Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action Department of Pharmaceutical Organic Chemistry 2023